Dermal Filler Market size was over USD 6.36 billion in 2024 and is expected to exceed USD 19.35 billion by the end of 2037, witnessing over 9.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of dermal filler is evaluated at USD 6.84 billion. The growth of the market is primarily attributed to the increasing number of surgical and non-invasive cosmetic procedures around the world. It was observed that a total of 13,280,000 cosmetic minimally-invasive procedures were performed in the United States in 2020, including a total of 110,000 soft tissue filler procedures between the ages of 50-70. Additionally, worldwide escalating prevalence of early skin aging issue is also propelling the growth of market over the forecast timeframe.
Dermal filler is an injectable, gel-like product that can improve physical features of the face and body. The purpose of these fillers is to restore the dermal volume and diminish wrinkles and other facial lines on the skin, thereby giving the patient a more youthful appearance. Therefore, surging demand for youthful skin, and scar removal is propelling the demand for dermal filler. Additionally, manufacturers are focusing on improving and developing new products including hyaluronic acid-based products to offer a wide variety of options to consumers which are expected to expand the global market size during the forecast period. For instance, it was observed that the number of cosmetic treatments including hyaluronic acid accounted for more than 2,870,000 procedures in 2019.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
9.3% |
|
Base Year Market Size (2024) |
USD 6.36 billion |
|
Forecast Year Market Size (2033) |
USD 19.35 billion |
|
Regional Scope |
|
Materials (Calcium Hydroxylapatite, Hyaluronic Acid, Poly-L-lactic Acid, PMMA, Fat}
The global dermal filler market is segmented and analyzed for demand and supply by materials into calcium hydroxylapatite, hyaluronic acid, poly-L-lactic acid, PMMA, fat, and others. Among these segments, the calcium hydroxylapatite segment – 72.2% is anticipated to capture the largest market size in the global market owing to the widespread use of soft tissue fillers for aesthetic restoration coupled with an increase in procedures involving calcium hydroxylapatite. For instance, out of the total cosmetic minimally invasive procedures performed in 2020, 201,474 involved the use of calcium hydroxylapatite.
Our in-depth analysis of the global market includes the following segments:
|
By Materials |
|
|
By Product |
|
|
By Application |
|
North America Market Forecast
The North America dermal filler market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037 backed by the economically stable population along with a higher percentage of cosmetic surgeries in the region. For instance, more than 15 million cosmetic procedures including surgical and non-invasive procedures were performed in United States in the year 2020. Moreover, the popularity of dermal filler procedures among population and the rise in R&D expenditures are projected to fuel dermal filler market growth in the region during the forecast period.
Galderma Laboratories - with an updated administration protocol, announced the re-launch of the injectable poly-L-lactic acid product Sculptra (injectable poly-L-lactic acid) in Europe.
Sinclair Company - has signed an exclusive worldwide licensing agreement for a new series of injectable hyaluronic acid treatments.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?